Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsis

NCT03940235 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Prostate Cancer

Interventions

DRUG: Androgen deprivation therapy (ADT)
RADIATION: SBRT

Sponsor

European Institute of Oncology